MEDICENTRAL
ActiveMEDICENTRAL has been active since 2009 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €222k and a net result of €65k. Equity is growing by ~29% per year across the filed fiscal years. Its solvency ranks better than 82% of 11297 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.8% (low).
Checked score
Score 2025
78
/ 100
Excellent
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability97▼-3
Solvency100=
Growth78=
Track record100
Bankruptcy probability, 12 months
0.8%
Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €17k at 30 days acceptable
Liquidity ample (current ratio 5.33 against 5.99 in 2024; short-term debt: 18.7% and cash: 1.6% of total assets), and 18.7% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Seven signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
81.3%
Return on assets
23.7%
Age of the figures
9 mo
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 46
Relative position
BE, all sectors
reference
Sector 46
higher
← fewer bankruptcies
more bankruptcies →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 23-07-2026, 8 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
8 d early
2024
29 d late
2023
29 d late
2022
60 d late
2021
22 d late
2020
31 d late
2019
112 d late
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
21-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, micro schema
Equity
€222k▲ 41.1%
2024 · €157k
2018: €35k
2019: €44k
2020: €52k
2021: €50k
2022: €62k
2023: €92k
2024: €157k
2018 → 2025
Total assets
€273k▲ 44.7%
2024 · €189k
2018: €57k
2019: €59k
2020: €71k
2021: €69k
2022: €75k
2023: €124k
2024: €189k
2018 → 2025
Net result
€65k▼ 1.5%
2024 · €66k
2018: €7k
2019: €9k
2020: €9k
2021: €-3k
2022: €12k
2023: €30k
2024: €66k
2018 → 2025
Working capital
€222k▲ 41.2%
2024 · €157k
2018: €34k
2019: €43k
2020: €52k
2021: €50k
2022: €62k
2023: €91k
2024: €157k
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€50k-€62k▲ 24.4%€92k▲ 47.8%€157k▲ 71.7%€222k▲ 41.1%
Operating result€4k-€17k▲ 335%€35k▲ 109%€83k▲ 136%€81k▼ 2.9%
Net result€-3k-€12k€30k▲ 143%€66k▲ 122%€65k▼ 1.5%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result falls in 2025; 2025 is 3% below 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €273k
Fixed assets
€300=
Current assets
€273k▲ 44.8%
Equity and liabilities €273k
Equity
€222k▲ 41.1%
Debt
€51k▲ 62.5%
The debt ratio rises from 16.7% to 18.7%. Equity and debt are higher.
Key figures and ratios
Solvency
81.3%▼
2024 · 83.3%
Current ratio
5.33▼
2024 · 5.99
Quick ratio
5.33▼
2024 · 5.99
Debt / equity
0.23▲
2024 · 0.20
ROE
29.1%▼
2024 · 41.8%
ROA
23.7%▼
2024 · 34.8%
Debt
€51k▲
2024 · €32k
Debt ≤ 1 year
€51k▲
2024 · €32k
Income taxes
€24k▼
2024 · €25k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€189k€273k▲
Fixed assets21/28€300€300=
Financial fixed assets28€300€300=
Current assets29/58€189k€273k▲
Amounts receivable within one year40/41€175k€269k▲
Trade receivables40€21k€7k▼
Other amounts receivable41€155k€262k▲
Cash at bank and in hand54/58€13k€4k▼
Deferred charges and accrued income490/1€150€0▼
Equity and liabilities
Total equity and liabilities10/49€189k€273k▲
Equity10/15€157k€222k▲
Contributions10/11€19k€19k=
Reserves13€2k€2k=
Non-distributable reserves130/1€2k€2k=
Reserves not available under the articles1311€2k€2k=
Profit (loss) carried forward14€137k€202k▲
Amounts payable17/49€32k€51k▲
Amounts payable within one year42/48€32k€51k▲
Trade debts44€7k€3k▼
Suppliers440/4€7k€3k▼
Taxes, remuneration and social security45€25k€48k▲
Taxes450/3€25k€48k▲
Income statement
Code20242025
Other operating charges640/8€387€400▲
Gross operating margin9900€83k€81k▼
Operating profit (loss)9901€83k€81k▼
Financial income75/76B€8k€8k▲
Recurring financial income75€8k€8k▲
Financial charges65/66B€40€36▼
Recurring financial charges65€40€36▼
Profit (loss) for the period before taxes9903€91k€88k▼
Income taxes67/77€25k€24k▼
Profit (loss) for the period9904€66k€65k▼
Profit (loss) for the period to be appropriated9905€66k€65k▼
Appropriation of the result
Profit (loss) to be appropriated9906€137k€202k▲
Profit (loss) brought forward from the previous period14P€71k€137k▲
The notes to these accounts (6 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
23-07
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
2025
31-12
Financial
Equity above €200kEq €222k ▲41.1%
4 profitable years in a row build equity to €222k.
29-08
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema · 29 days late
2024
31-12
Financial
Highest result since 2018net €66k ▲122%
Operating result €83k, net result €66k, both a record.
31-12
Financial
Equity above €150kEq €157k ▲71.7%
3 profitable years in a row build equity to €157k.
29-08
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema · 29 days late
2023
29-09
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema · 60 days late
2022
31-12
Financial
Back to profitnet €12k
Net result €12k after one loss-making year.
22-08
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema · 22 days late
2021
31-12
Financial
Weakest financial yearnet €-3k ▼130%
Net result drops to €-3k, the lowest in the series; recovery starts the following year.
31-08
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema · 31 days late
2020
20-11
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema · 112 days late
2019
04-12
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema · 126 days late
2018
27-09
NBB filing
Annual accounts filed
fiscal year 2017 · micro schema · 58 days late
2017
02-11
NBB filing
Annual accounts filed
fiscal year 2016 · micro schema · 94 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Elsene · 1 establishment unit since 2009
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Louizalaan 2311050 ElseneGround area
9,201 m²
Building footprint
5,756 m²
Volume, LiDAR
130,454 m³
2 parcels, Brussels · tallest building 45.8 m, ±8 floors. Linked by address, not a title deed.
1 establishment unit
MEDICENTRAL
since 20092.185.824.625
2 parcels
Brussels
2
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 21807G0131/00T000 | Brussels | 5,672 m² | 1 · 3,878 m² | 45.8 m · 8 fl. |
| 21822R0226/00W011 | Brussels | 3,529 m² | 1 · 1,878 m² | 38.1 m · 7 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1 · via establishment units: 1
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
STIJLINTERIEUR
BE 0429.290.524
Geraardsbergen · Eq €222k
OPTIEK SNOECK
BE 0463.987.028
Deinze · Eq €221k
L'ENTREPOOL
BE 0680.704.527
Chaumont-Gistoux · Eq €224k
CHEMFOR
BE 0889.757.640
Plombières · Eq €221k
Allion
BE 0743.375.336
Turnhout · Eq €220k
Of 1,745 companies in sector 46150 we hold annual accounts for 757. 530 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company (pre-2019)
Founded28-12-2009
Fiscal year end31-12
Activities, NACEBEL
46150Agents in the wholesale of furniture, household goods and hardware
46180Agents specialised in the wholesale of other particular products
46460Wholesale of pharmaceutical and medical goods
77225Rental and leasing activities
Sources
Crossroads Bank for EnterprisesNational Bank · 16 filingsAddress and cadastre registers
Data from official sources, last processed on 20-09-2026. Scores and ratios are computed by Checked and are not a credit decision.